La cadena de opciones muestra datos clave de las opciones de acciones de Royalty Pharma a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Royalty Pharma..

Royalty Pharma (NASDAQ:RPRX) Bolsa, Cadena de Opciones

Royalty Pharma

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Long Ideas

News

Markets

Media

Trading Ideas

ALLY

Core Scientific, Inc. - Class A Common Stock

CORZ

RPRX

SNOW

Descubre por qué Jim Cramer respalda a Ally Financial y qué opinan los analistas sobre Snowflake, Royalty Pharma y Core Scientific.

Jim Cramer evalúa el futuro de Ally, Snowflake, Royalty Pharma y Core Scientific

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma PLC

Press Releases

Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition

Royalty Pharma to Present at Upcoming Investor Conferences

Royalty Pharma Completes the Acquisition of Its External Manager

Health Care

Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Financing

Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

Management

Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors

Dividends

Royalty Pharma Declares Third Quarter 2025 Dividend

Earnings

Royalty Pharma Reports Second Quarter 2025 Results

Henry Fernandez Steps Down from Royalty Pharma's Board of Directors

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Perrigo

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Royalty Pharma

Royalty Pharma (RPRX) Opciones

Royalty Pharma (NASDAQ:RPRX) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL